Diagnostics
Test will specifically adjust for isatuximab-induced interference in complete response assessment of multiple myeloma patients
Sphingotec reports study data demonstrating that its proprietary renal function biomarker penKid(R) (Proenkephalin) predicts acute kidney injury (AKI), multi-organ failure and mortality in sepsis patients presenting to the emergency department (ED).
Data from more than 1,200 patients of the PROTECT study demonstrate that high levels of the endothelial function biomarker bio-ADM(R) (bioactive Adrenomedullin) indicate residual congestion of heart failure patients.
At the six-year mark, 90.6% of patients in the Perjeta cohort have not had breast cancer return, compared to 87.8% in the placebo arm. This comes to an absolute benefit of 2.8%.
Owlstone Medical will receive funding to deploy Breath Biopsy® as part of EPHOR
“We still have some work in front of us, but we’re happy where we are,” said Jeff Hawkins, CEO of Truvian Sciences.
Saphyr provides a platform that streamlines traditional workflows and provides a path to solving previously intractable scientific questions connected to the mechanisms of disease
Epigenomics AG announced its financial results for the first nine months of 2019.
Ellume Limited is pleased to announce the appointment of Ms Joanne Moss to its Board as an Independent Non-Executive Director and Chair of Audit and Risk, effective immediately.
Roche intends to hold two global meetings with members of the DMD community to provide the stakeholders with as much information as possible.
PRESS RELEASES